8-K: Applied UV and SteriLumen File for Chapter 11 Bankruptcy, Nasdaq Delisting Imminent

Applied UV, Inc. and its subsidiary SteriLumen, Inc. have filed for Chapter 11 bankruptcy, leading to the delisting of their stock from Nasdaq.

Summary

• Applied UV, Inc. and its wholly-owned subsidiary, SteriLumen, Inc., have both filed for Chapter 11 bankruptcy on May 24, 2024.
• The companies will operate as debtors-in-possession while under the jurisdiction of the Bankruptcy Court.
• They intend to use their available cash, approximately $10,000 for Applied UV and $55,000 for SteriLumen, to fund operations during the bankruptcy process.
• The company's common stock and Series A Preferred Stock are expected to be delisted from Nasdaq.
• Trading of the company's stock will be suspended on June 4, 2024.
• The company does not intend to appeal the delisting decision.
• The company cautions that trading in its stock is highly speculative and poses substantial risks.
• There is no guarantee that shareholders will receive any payment or distribution on their shares following the bankruptcy proceedings.

Sentiment

Score: 1

Explanation: The document indicates a severe negative event with the company filing for bankruptcy and being delisted from Nasdaq, indicating a very negative outlook for investors.

Negatives

• The company has filed for Chapter 11 bankruptcy.
• The company's stock will be delisted from Nasdaq.
• Shareholders may not receive any payment or distribution on their shares.
• Trading in the company's stock is highly speculative and poses substantial risks.

Risks

• The company's ability to continue operations during the Chapter 11 process is uncertain.
• The value of the company's stock is highly speculative.
• Shareholders may lose their entire investment.
• The company faces significant financial challenges.

Future Outlook

The company intends to continue operations as a debtor-in-possession while under the jurisdiction of the Bankruptcy Court, but the future value of the company's stock and the possibility of any distribution to shareholders is uncertain.

Management Comments

• The company cautions that trading in its stock is highly speculative and poses substantial risks.
• The company urges extreme caution with respect to existing and future investments in its common stock and Series A Preferred Stock.

Industry Context

This announcement reflects significant financial distress for Applied UV and SteriLumen, which may indicate broader challenges in their specific market segment or the overall economic environment. The bankruptcy filing and delisting are likely to negatively impact investor confidence in similar companies.

Comparison to Industry Standards

• The bankruptcy filing is a significant negative event, indicating severe financial distress, which is not typical for companies listed on the Nasdaq.
• The delisting of the stock is a rare occurrence for companies that have been listed on a major exchange like Nasdaq, suggesting a failure to meet the exchange's listing requirements.
• The low cash balances of $10,000 and $55,000 for Applied UV and SteriLumen respectively, are significantly below the typical cash reserves of publicly traded companies, indicating a severe liquidity crisis.

Legal Proceedings

• Applied UV, Inc. and SteriLumen, Inc. have filed voluntary petitions for relief under chapter 11 of title 11 of the United States Bankruptcy Code.

Stakeholder Impact

• Shareholders face the risk of losing their entire investment.
• Employees may face uncertainty regarding their employment.
• Creditors may face the risk of not being fully repaid.
• Customers and suppliers may experience disruptions in their business relationships with the company.

Next Steps

• The company will continue to operate as a debtor-in-possession under the jurisdiction of the Bankruptcy Court.
• The company will seek approval of first day motions to continue ordinary course operations.
• The company's stock will be delisted from Nasdaq on June 4, 2024.

Key Dates

Keywords

bankruptcy, chapter 11, delisting, Nasdaq, stock, SteriLumen, Applied UV, debtor-in-possession